Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-29

Clinical Trial Update: Sevoflurane and Hyperperfusion Syndrome [NA]

View source ↗

Summary

This clinical trial update concerns sevoflurane in relation to hyperperfusion syndrome and Moyamoya disease, with an unknown trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hyperperfusion Syndrome, Moyamoya Disease | NA | Status: UNKNOWN